Announcements Trials
Browse Landscape

Status

Approved for marketing 2No longer available 1

Sponsor Class

OTHER 1

Study Type

Expanded_access 1

Sponsor

Conditions

Lambert-Eaton Myasthenic Syndrome 4Myasthenic Syndromes, Congenital 1

Interventions

Amifampridine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
No longer available × Myasthenic Syndromes, Congenital × Amifampridine × Clear all
NCT02012933 2019-12-11

3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome (LEMS) and Congenital Myasthenia (CM)

Oregon Health and Science University

No longer available

Lambert-Eaton Myasthenic Syndrome, Myasthenic Syndromes, Congenital

Data powered by HemOnc (CC BY 4.0) Colophon âš¡